MALAT1 and hepatocellular carcinoma: We then analyzed the diagnostic performance of EV‐DLEU2, EV‐HOTTIP, EV‐MALAT1, and EV‐SNHG1 for HCC in the validation cohort, comprising 72 subjects with HCC and 67 subjects without HCC.